Decrease of Mitochondrial DNA Content and Energy Metabolism in Renal Cell Carcinoma
Overview
Authors
Affiliations
To elucidate the relationship between tumor genesis and the mitochondrial energy metabolism in renal neoplasms, we studied three individual enzyme activities of the oxidative phosphorylation, two components of the Krebs cycle and the mitochondrial DNA content of renal carcinomas including 29 conventional, five papillary, two unclassified carcinomas with sarcomatoid features and one collecting duct carcinoma. A significant reduction of all mitochondrial enzyme activities including complex V, as well as of the mitochondrial DNA content was detected in 34 of 37 renal carcinoma tissues as compared with control kidney. Mitochondrial enzyme activities and mitochondrial DNA levels were not statistically different between the conventional, papillary and unclassified sarcomatoid type of renal carcinoma and did not correlate with tumour grade, metastasis, ploidy and proliferative activity as determined by Ki-67 staining. Taken together, our data indicate that a co-ordinated down-regulation of all components necessary for mitochondrial energy metabolism occurs in most renal carcinomas as an early event in carcinoma formation, which does not change with progression of the disease.
C17orf80 binds the mitochondrial genome to promote its replication.
Wu H, Zhang W, Xu F, Peng K, Liu X, Ding W J Cell Biol. 2023; 222(10).
PMID: 37676315 PMC: 10484793. DOI: 10.1083/jcb.202302037.
Mitochondrial DNA - novel mechanisms of kidney damage and potential biomarker.
Malik A Curr Opin Nephrol Hypertens. 2023; 32(6):528-536.
PMID: 37661939 PMC: 10552826. DOI: 10.1097/MNH.0000000000000922.
Zhang W, Wu F Reprod Biol Endocrinol. 2023; 21(1):27.
PMID: 36932444 PMC: 10021953. DOI: 10.1186/s12958-023-01078-6.
Updates on the Pivotal Roles of Mitochondria in Urothelial Carcinoma.
Huang C, Liu H, Hsu T, Lee W Biomedicines. 2022; 10(10).
PMID: 36289714 PMC: 9599371. DOI: 10.3390/biomedicines10102453.
Insights regarding mitochondrial DNA copy number alterations in human cancer (Review).
Abd Radzak S, Mohd Khair S, Ahmad F, Patar A, Idris Z, Yusoff A Int J Mol Med. 2022; 50(2).
PMID: 35713211 PMC: 9304817. DOI: 10.3892/ijmm.2022.5160.